White Willow is a modern hybrid-indica strain developed through the crossing of Afghani and Hawaiian genetics. This cultivar is categorized as a project of moderate cultivation difficulty, which is suited for both indoor and outdoor environments. Growers can expect a high yield from this plant, with the flowering phase typically concluding after 70 days. Its genetic influence has also extended into the development of later hybrids, most notably serving as a foundation for G13 Haze White Willow.

The complex organoleptic profile of White Willow is defined by a broad spectrum of compounds, led by dominant levels of terpinolene, myrcene, and pinene. This primary foundation is followed by secondary and tertiary contributions from limonene, caryophyllene, ocimene, beta-pinene, humulene, and linalool. The aromatic and flavor profile is further nuanced by the presence of bisabolol, guaiol, alpha-terpinene, nerolidol, and gamma-terpinene, creating a multifaceted chemical structure.

As a THC-dominant variety, White Willow is characterized by effects that facilitate a sense of relaxation, calmness, and mental focus. These therapeutic properties make the strain a utilized option for users addressing physical pain, elevated stress, and sleep difficulties. Through its specific terpene synthesis and cannabinoid content, the strain remains a consistent tool for those seeking a balanced, restorative experience.